ESR1 and breast cancer: Triple-negative breast cancer (TNBC) refers to breast cancer with negative ER (estrogen receptor), PR (progesterone receptor), and HER2 (human epidermal growth factor receptor 2) expression; TNBC has a high incidence, accounting for 10–20% of breast cancers (2).